Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Retained Earnings: 2019-2024

Historic Retained Earnings for Legend Biotech (LEGN) over the last 6 years, with Dec 2024 value amounting to $1.0 billion.

  • Legend Biotech's Retained Earnings fell 9.39% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year decrease of 9.39%. This contributed to the annual value of $1.0 billion for FY2024, which is 16.81% down from last year.
  • Latest data reveals that Legend Biotech reported Retained Earnings of $1.0 billion as of FY2024, which was down 16.81% from $1.3 billion recorded in FY2023.
  • In the past 5 years, Legend Biotech's Retained Earnings registered a high of $1.3 billion during FY2023, and its lowest value of $597.7 million during FY2020.
  • In the last 3 years, Legend Biotech's Retained Earnings had a median value of $1.0 billion in 2024 and averaged $1.0 billion.
  • As far as peak fluctuations go, Legend Biotech's Retained Earnings spiked by 295.04% in 2020, and later decreased by 16.81% in 2024.
  • Yearly analysis of 5 years shows Legend Biotech's Retained Earnings stood at $597.7 million in 2020, then climbed by 28.16% to $766.0 million in 2021, then dropped by 2.87% to $744.0 million in 2022, then soared by 68.19% to $1.3 billion in 2023, then fell by 16.81% to $1.0 billion in 2024.